Future Market Insights projects the sector will grow from USD 641.5 million in 2026 at an 8.0% CAGR, supported by demand for premium infant formula, protein-enriched products and plant-based ingredients.
The global high-protein infant nutrition ingredients market is projected to grow from USD 641.5 million in 2026 to USD 1,390.0 million by 2036, expanding at an 8.0% CAGR, according to Future Market Insights. FMI said demand is being driven by infant nutrition manufacturers' focus on protein-enriched formulations designed to support growth, immunity and cognitive development, alongside rising consumer interest in premium infant nutrition and increasing awareness of early-life nutrition. The report also pointed to growing investment in functional protein ingredients, advances in ingredient processing technologies and expanding adoption of plant-based infant nutrition solutions. Proteins are expected to lead the product-type segment with a 24.0% market share in 2026, reflecting their central role in infant formula and other nutrition products. Plant-based ingredients are projected to account for 18.0% of source demand in 2026 as manufacturers pursue sustainable, hypoallergenic and alternative formulations. Infant formula remains the largest application segment. FMI said North America is expected to retain a significant share of the market, while Europe is seen posting steady growth. Asia Pacific is forecast to expand the fastest during the period, supported by rising birth rates in emerging economies, growing middle-class populations, increasing disposable incomes and stronger awareness of infant health and nutrition. The report named Arla Foods Ingredients, Fonterra Co-operative Group, FrieslandCampina Ingredients, Kerry Group plc, Glanbia Nutritionals, Royal DSM, Ingredia SA, Hilmar Ingredients, Lactalis Ingredients and Agropur Ingredients among key companies.